These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31568060)

  • 1. Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.
    Bokrantz T; Schiöler L; Boström KB; Kahan T; Mellström D; Ljungman C; Hjerpe P; Hasselström J; Manhem K
    J Hypertens; 2020 Jan; 38(1):167-175. PubMed ID: 31568060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
    Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
    BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drugs demonstrate varying levels of hip fracture risk: A systematic review and meta-analysis.
    Langerhuizen DWG; Verweij LPE; van der Wouden JC; Kerkhoffs GMMJ; Janssen SJ
    Injury; 2022 Mar; 53(3):1098-1107. PubMed ID: 34627629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
    Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of antihypertensive drugs on the risk of new-onset diabetes in elderly Taiwanese hypertensives.
    Liou YS; Ma T; Tien L; Chien C; Chou P; Jong GP
    Int Heart J; 2008 Mar; 49(2):205-11. PubMed ID: 18475020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies.
    Wiens M; Etminan M; Gill SS; Takkouche B
    J Intern Med; 2006 Oct; 260(4):350-62. PubMed ID: 16961672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.
    Barzilay JI; Davis BR; Pressel SL; Ghosh A; Puttnam R; Margolis KL; Whelton PK
    Curr Cardiol Rep; 2017 Sep; 19(9):76. PubMed ID: 28752275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort Study.
    Chen HY; Ma KY; Hsieh PL; Liou YS; Jong GP
    Chin Med J (Engl); 2016 Dec; 129(24):2907-2912. PubMed ID: 27958221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of hip fracture after initiating antihypertensive drugs in the elderly.
    Butt DA; Mamdani M; Austin PC; Tu K; Gomes T; Glazier RH
    Arch Intern Med; 2012 Dec; 172(22):1739-44. PubMed ID: 23165923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
    Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
    Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antihypertensive therapy among patients with COPD.
    Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
    Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
    Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
    J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between antihypertensive therapy and the incidence of Parkinson's disease in patients followed in general practices in Germany
.
    Warda A; Reese JP; Tanislav C; Kostev K
    Int J Clin Pharmacol Ther; 2019 Oct; 57(10):483-488. PubMed ID: 31426904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients.
    Song HJ; Lee J; Kim YJ; Jung SY; Kim HJ; Choi NK; Park BJ
    Bone; 2012 Dec; 51(6):1008-15. PubMed ID: 22960238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort.
    Padwal R; Mamdani M; Alter DA; Hux JE; Rothwell DM; Tu K; Laupacis A
    Diabetes Care; 2004 Oct; 27(10):2458-63. PubMed ID: 15451916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD; Kaciroti N; Bakris G; Dahlöf B; Pitt B; Velazquez E; Weber M; Zappe DH; Hau T; Jamerson KA
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.